Volume : 10, Issue : 11, November – 2023
Title:
LUBRICANTS TO IMPROVE ORAL MEDICATION SWALLOWING AND COMPLIANCE
Authors :
Ketaki Jawalekar*, Mohit Bajaj , Krishna Vaishnav, Anuj Deshmukh, Shreyash Padmawar
Abstract :
Medication lubricants are thick liquids or gels that are designed to aid swallowing of solid oral dosage forms. Tablets and capsules are placed within a spoonful of the product for swallowing. The aim of this study was to describe and compare commercially available medication lubricants in terms of textural suitability for patients with dysphagia. Twelve medication lubricants were characterised according to the International Dysphagia Diet Standardisation Initiative (IDDSI) framework. Apparent viscosity, yield stress, thickness consistency, and various texture features were compared. Gloup Forte was the only medication lubricant classified as IDDSI level4 (pureed/extremely thick) at room (24 ◦C) temperature. Four other Gloup products were IDDSI level 3 (liquidized /moderately thick) at room temperature but testing at 4 ◦C or pouring from the container instead of using the pump dispenser resulted in classification as IDDSI level 4. The IDDSI Flow test would have classified Medi Spend and Slo Tablets as IDDSI level 3, but their very low yield stress led to these fluids flowing too quickly through the prongs of a fork and so these were classified as <3. Severo was IDDSI level 2. Heyaxon and the two versions of Magic Jelly tested contained lumps, and Swallow Aid had exceptionally high viscosity, hardness, adhesiveness, and gumminess, classifying them as IDDSI Level 7 (“regular textures”) and therefore as unsuitable for people with dysphagia according to IDDSI. This study provides valuable information to help with the selection of a safe medication lubricant with appropriate thickness level suited to each individual with dysphagia.
Keywords: Dysphagia, swallow, Lubricant,Compliance, Hygroscopic.
Cite This Article:
Please cite this article in Ketaki Jawalekar et al, Lubricants To Improve Oral Medication Swallowing And Compliance, Indo Am. J. P. Sci, 2023; 10 (11).
Number of Downloads : 10
References:
1)Kozarewicz, P., 2014. Regulatory perspectives on acceptability testing of dosage forms in children. International journal of pharmaceutics, 469(2), pp.245-248.
2)Punzalan, C., Budnitz, D.S., Chirtel, S.J., Geller, A.I., Jones, O.E., Mozersky, R.P. and Wolpert, B., 2019. Swallowing problems and dietary supplements: data from US Food and drug administration adverse event reports, 2006-2015. Annals of internal medicine, 171(10), pp.771-773.
3)Siegel, D., Lopez, J. And Meier, J., 2007. Antihypertensive medication adherence in the Department of Veterans Affairs. The American journal of medicine, 120(1), pp.26-32
4)Matsuo, K. And Palmer, J.B., 2008. Anatomy and physiology of feeding and swallowing: normal and abnormal. Physical medicine and rehabilitation clinics of North America, 19(4), pp.691-707..
5)Stegemann, S., Gosch, M. And Breitkreutz, J., 2012. Swallowing dysfunction and dysphagia is an unrecognized challenge for oral drug therapy. International journal of pharmaceutics, 430(1-2), pp.197-206.
6)Kramer, S.S. and Monahan Eicher, P., 1993. The evaluation of pediatric feeding abnormalities. Dysphagia, 8(3), pp.215-224.
7)Liu, F., Ranmal, S., Batchelor, H.K., Orlu-Gul, M., Ernest, T.B., Thomas, 1.W., Flanagan, T. And Tuleu, C., 2014. Patient-centered pharmaceutical design to improve acceptability of medicines: similarities and differences in paediatric and geriatric populations. Drugs, 74(16), pp.1871-1889.
8)Kelly, J. And Wright, D., 2009. Administering medication to adult patients with dysphagia. Nursing Standard (through 2013), 23(29), p.62.
9)Steele, C.M., Greenwood, C., Ens, I., Robertson, C. And Seidman-Carlson, R., 1997. Mealtime difficulties in a home for the aged: not just dysphagia. Dysphagia, 12(1), pp.43-50.
10)Niezgoda, H., Keller, H.H., Steele, C.M. and Chambers, L.W., 2014. What should a case-finding tool for dysphagia in long term care residents with dementia look like? Journal of the American Medical Director
11)Khan, A., Carmona, R. And Traube, M., 2014. Dysphagia in the elderly. Clinics in geriatric medicine, 30(1), pp.43-53.
12)Heppner, H.J., Sieber, C.C., Esslinger, A.S. and Trögner, J., 2006. Drug administration and dosage forms in geriatric patients. Therapeutische Umschau. Revue Therapeutique, 63(6), pp.419-422,
13)Tahaineh, L. And Wazaify, M., 2017. Difficulties in swallowing oral medications in Jordan. International journal of clinical pharmacy, 39(2), pp.373-379.
14)European Medicines Agency, 2011. Committee for medicinal products for human use. Guideline on Bioanalytical Method Validation
15)Klingmann, V., Spomer, N., Lerch, C., Stoltenberg, I., Frömke, C., Bosse, H.M., Breitkreutz, J. And Meissner, T., 2013. Favorable acceptance ofmini- tablets compared with syrup: a randomized controlled trial in infants and preschool children. The Journal of pediatrics, 163(6), pp.1728-1732..
16)Van Riet-Nales, D.A., de Neef, B.J., Schobben, A.F., Ferreira, J.A., Egberts, T.C. and Rademaker, C.M., 2013. Acceptability of different oral formulations in infants and preschool children. Archives of disease in childhood, 98(9), pp.725-731.
17)Thomson, S.A., Tuleu, C., Wong, L.C., Keady, S., Pitt, K.G. and Sutcliffe, A.G., 2009. Minitablets: new modality to deliver medicines to preschool- aged children. Pediatrics, 123(2), pp.e235-e238.
18)Meltzer, E.O., Welch, M.J. and Ostrom, N.K., 2006. Pill swallowing ability and training in children 6 to 11 years of age. Clinical pediatrics, 45(8), pp.725-733.
19)Yamamoto, S., Taniguchi, H., Hayashi, H., Hori, K., Tsujimura, T., Nakamura, Y., Sato, H. And Inoue, M., 2014. How do tablet properties influence swallowing behaviours?. Journal of Pharmacy and Pharmacology, 66(1), pp.32-39.
20)Hey, H., Jørgensen, F., Sørensen, K., Hasselbalch, H. And Wamberg, T., 1982. Oesophageal transit of six commonly used tablets and capsules. Br Med J (Clin Res Ed), 285(6356), pp.1717-1719.
21)Perkins, A.C., Wilson, C.G., Blackshaw, P.E., Vincent, R.M., Dansereau, R.J., Juhlin, K.D., Bekker, P.J. and Spiller, R.C., 1994. Impaired oesophageal transit of capsule versus tablet formulations in elderly. Gut, 35(10), pp.1363-1367. The
22)Robertson, C.S. and Hardy, J.G., 1988. Oesophageal transit of small tablets. Journal of pharmacy and pharmacology, 40(8), pp.595-596.
23)Wang, J., Wen, H. And Desai, D., 2010. Lubrication in tabletFormulations. European journal of Biopharmaceutics, 75(1), pp.1-15.Pharmaceutics.
24)Zuurman, K., Van der Voort Maarschalk, K. And Bolhuis, G.K., 1999. Effect of magnesium stearate on bonding and porosity expansion of tablets produced from materials with different consolidation properties. International journal of pharmaceutics, 179(1), pp. 107-115.
25)Faqih, A.M.N., Mehrotra, A., Hammond, S.V. and Muzzio, F.J., 2007. Effect of moisture and magnesium stearate concentration on flow properties of cohesive granular materials. International journal of pharmaceutics, 336(2), pp.338-345.
26)Paul, S., Taylor, L.J., Murphy, B., Krzyzaniak, J., Dawson, N., Mullarney, M.P., Meenan, P. And Sun, C.C., 2017. Mechanism and kinetics of punch sticking of pharmaceuticals. Journal of pharmaceutical sciences, 106(1), pp.151-158.
27)Paul, S. And Sun, C.C., 2017. Gaining insight into tablet capping tendency from compaction simulation. International pharmaceutics, 524(1-2), pp.111-120.
28)Sun, C.C., 2011. Decoding powder tabletability: roles of particle adhesion and plasticity. Journal of Adhesion Science and Technology, 25(4-5), pp.483-499.
29)Johnson, B., Greer, H., Mccrerie, J., Bye, C. And Fowle, A., 1973. Rate of dissolution of digoxin tablets as a predictor of absorption. The Lancet, 301(7818), pp.1473-1475.
30)Lee, C.H. and Maibach, H.I., 1995. The sodium lauryl sulfate model: an overview. Contact dermatitis, 33(1), pp.1-7.
31)Dun, J., Osei-Yeboah, F., Boulas, P., Lin, Y. And Sun, C.C., 2018. A systematic evaluation of dual functionality of sodium lauryl sulfate as a tablet lubricant wetting enhancer. International journal of pharmaceutics, 552(1-2), pp.139-147.
32)Ugelstad, J., El-Aasser, M.S. and Vanderhoff, J.W., 1973. Emulsion Polymerization: Initiation of polymerization in monomer droplets. Journal of Polymer Science: Polymer Letters Edition, 11(8), pp.503-513.
33)Lee, C.H. and Maibach, H.I., 1995. The sodium lauryl sulfate model: an Overview. Contact dermatitis, 33(1), pp.1-7.
34)Patel, H.R., Patel, R.P. and Patel, M.M., 2009. Poloxamers: A pharmaceutical excipients with therapeutic behaviors. International Journal of PharmTech Research, 1(2), pp.299-303.
35) Reddy, R.K., Khalil, S.A. and Gouda, M.W., 1976. Effect of dioctyl sodium sulfosuccinate and poloxamer 188 on dissolution and intestinal absorption of sulfadiazine and sulfisoxazole in rats. Journal of pharmaceutical sciences, 65(1), pp. 115-118.